111 Inc
NASDAQ:YI
111 Inc
Total Other Income
111 Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Total Other Income
¥7.6m
|
CAGR 3-Years
36%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Total Other Income
¥1.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Total Other Income
¥7.6m
|
CAGR 3-Years
56%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Total Other Income
-¥3.5m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Total Other Income
-¥16.6m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Total Other Income
-¥82.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Total Other Income?
Total Other Income
7.6m
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Total Other Income amounts to 7.6m CNY.
What is 111 Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
-9%
Over the last year, the Total Other Income growth was -5%. The average annual Total Other Income growth rates for 111 Inc have been 36% over the past three years , -9% over the past five years .